linkedin
 
You Are On
Equity
Equity Analysis
News Analysis
Corporate Action
Corporate Info
Derivatives
Other Market
Research
 
 Company News  
Biocon Ltd.
 
BSE Code 532523
ISIN Demat INE376G01013
Book Value 166.61
NSE Code BIOCON
Dividend Yield % 0.14
Market Cap 597952.88
P/E 8080.44
EPS 0.05
Face Value 5  
30-Apr-2026 USFDA completes Pre-License inspection at Biocon’...
30-Apr-2026 Biocon informs about company statement
21-Apr-2026 Biocon’s Bosaya, Vevzuo get NoC from Health Canada
21-Apr-2026 Biocon informs about press release
21-Apr-2026 Biocon surges as its Bosaya, Vevzuo get NoC from ...
08-Apr-2026 Biocon’s arm gets USFDA’s nod for Dapagliflozin T...
08-Apr-2026 Biocon informs about media release
08-Apr-2026 Biocon surges as its arm gets USFDA’s nod for Dap...
07-Apr-2026 Biocon launches Bosaya, Aukelso in US
13-Mar-2026 Biocon’s arm gets USFDA’s nod for ANDA of Liraglu...
05-Mar-2026 Biocon informs about analyst meet
25-Feb-2026 Biocon gets USFDA’s nod for Liraglutide Injection
25-Feb-2026 Biocon inches up on getting USFDA’s nod for Lirag...
25-Feb-2026 Biocon informs about investor presentation
17-Feb-2026 Biocon informs about investors meet
Page 1 of 7
Prev || Next
 
RMS | Policies & Procedures| PMLA | Disclaimer | Privacy Policy | Web Mail | Relationship | Investor Grievance
Career | Contact Us| KYC| PMS Risk Disclosure | Key Managerial Person | Basic Details | Process of Opening an Account | Process of Filing Complaint
Links to MCX | NCDEX |FMC | NCDEX CMID NCDEX-CO-04-00129 | MCX 10550 | FMC MCX: MCX/TCM/CORP/0008| FMC NCDEX : NCDEX/TCM/CORP/0274    
NSE: INB230914036 |NSE F & O INF230914036 |BSE: INB010914032 |BSE F & O: INF010914032 | CDSL: IN-DP-CDSL-335-2006 | OTC: INB200914032
Related Sites: Bombay Stock Exchange (BSE), Investor Protection, National Stock Exchange (NSE), Securities & Exchange Board of India (SEBI)
© Padmakshi 2009. All Rights Reserved. Designed || Developed & Content Powered By Accord Fintech Pvt. Ltd.